Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations - PubMed (original) (raw)

Comparative Study

Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations

Birgit Neuhuber et al. Brain Res. 2005.

Abstract

Bone marrow stromal cells (MSC) are non-hematopoietic support cells that can be easily derived from bone marrow aspirates. Human MSC are clinically attractive because they can be expanded to large numbers in culture and reintroduced into patients as autografts or allografts. We grafted human MSC derived from aspirates of four different donors into a subtotal cervical hemisection in adult female rats and found that cells integrated well into the injury site, with little migration away from the graft. Immunocytochemical analysis demonstrated robust axonal growth through the grafts of animals treated with MSC, suggesting that MSC support axonal growth after spinal cord injury (SCI). However, the amount of axon growth through the graft site varied considerably between groups of animals treated with different MSC lots, suggesting that efficacy may be donor-dependent. Similarly, a battery of behavioral tests showed partial recovery in some treatment groups but not others. Using ELISA, we found variations in secretion patterns of selected growth factors and cytokines between different MSC lots. In a dorsal root ganglion explant culture system, we tested efficacy of conditioned medium from three donors and found that average axon lengths increased for all groups compared to control. These results suggest that human MSC produce factors important for mediating axon outgrowth and recovery after SCI but that MSC lots from different donors vary considerably. To qualify MSC lots for future clinical application, such notable differences in donor or lot-lot efficacy highlight the need for establishing adequate characterization, including the development of relevant efficacy assays.

PubMed Disclaimer

Cited by

Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury.
Nakajima H, Uchida K, Guerrero AR, Watanabe S, Sugita D, Takeura N, Yoshida A, Long G, Wright KT, Johnson WE, Baba H. Nakajima H, et al. J Neurotrauma. 2012 May 20;29(8):1614-25. doi: 10.1089/neu.2011.2109. Epub 2012 Apr 18. J Neurotrauma. 2012. PMID: 22233298 Free PMC article.
Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice.
Shen LH, Xin H, Li Y, Zhang RL, Cui Y, Zhang L, Lu M, Zhang ZG, Chopp M. Shen LH, et al. Stroke. 2011 Feb;42(2):459-64. doi: 10.1161/STROKEAHA.110.593863. Epub 2011 Jan 6. Stroke. 2011. PMID: 21212396 Free PMC article.
Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications.
Wright KT, El Masri W, Osman A, Chowdhury J, Johnson WE. Wright KT, et al. Stem Cells. 2011 Feb;29(2):169-78. doi: 10.1002/stem.570. Stem Cells. 2011. PMID: 21732476 Free PMC article. Review.
Human olfactory mesenchymal stromal cell transplants promote remyelination and earlier improvement in gait co-ordination after spinal cord injury.
Lindsay SL, Toft A, Griffin J, M M Emraja A, Barnett SC, Riddell JS. Lindsay SL, et al. Glia. 2017 Apr;65(4):639-656. doi: 10.1002/glia.23117. Epub 2017 Feb 1. Glia. 2017. PMID: 28144983 Free PMC article.
Regulation of Immunity via Multipotent Mesenchymal Stromal Cells.
Rubtsov YP, Suzdaltseva YG, Goryunov KV, Kalinina NI, Sysoeva VY, Tkachuk VA. Rubtsov YP, et al. Acta Naturae. 2012 Jan;4(1):23-31. Acta Naturae. 2012. PMID: 22708060 Free PMC article.

Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations - PubMed (original) (raw)